119 related articles for article (PubMed ID: 29564829)
1. Expression of Genes Associated with Telomere Homeostasis in TP53 Mutant LoVo Cell Lines as a Model for Genomic Instability.
Samassekou O; Bastien N; Yan J; Mai S; Drouin R
Methods Mol Biol; 2018; 1769():253-262. PubMed ID: 29564829
[TBL] [Abstract][Full Text] [Related]
2. Study of Telomere Dysfunction in TP53 Mutant LoVo Cell Lines as a Model for Genomic Instability.
Samassekou O; Bastien N; Yan J; Mai S; Drouin R
Methods Mol Biol; 2018; 1769():209-230. PubMed ID: 29564827
[TBL] [Abstract][Full Text] [Related]
3. Different TP53 mutations are associated with specific chromosomal rearrangements, telomere length changes, and remodeling of the nuclear architecture of telomeres.
Samassekou O; Bastien N; Lichtensztejn D; Yan J; Mai S; Drouin R
Genes Chromosomes Cancer; 2014 Nov; 53(11):934-50. PubMed ID: 25059482
[TBL] [Abstract][Full Text] [Related]
4. Correlation of telomere length shortening with TP53 somatic mutations, polymorphisms and allelic loss in breast tumors and esophageal cancer.
Hao XD; Yang Y; Song X; Zhao XK; Wang LD; He JD; Kong QP; Tang NL; Zhang YP
Oncol Rep; 2013 Jan; 29(1):226-36. PubMed ID: 23124483
[TBL] [Abstract][Full Text] [Related]
5. Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions.
Thomay K; Fedder C; Hofmann W; Kreipe H; Stadler M; Titgemeyer J; Zander I; Schlegelberger B; Göhring G
Ann Hematol; 2017 Sep; 96(9):1493-1500. PubMed ID: 28691153
[TBL] [Abstract][Full Text] [Related]
6. The presence of telomere fusion in sporadic colon cancer independently of disease stage, TP53/KRAS mutation status, mean telomere length, and telomerase activity.
Tanaka H; Beam MJ; Caruana K
Neoplasia; 2014 Oct; 16(10):814-23. PubMed ID: 25379018
[TBL] [Abstract][Full Text] [Related]
7. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines.
Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH
Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280
[TBL] [Abstract][Full Text] [Related]
8. Lack of major genome instability in tumors of p53 null rats.
Hermsen R; Toonen P; Kuijk E; Youssef SA; Kuiper R; van Heesch S; de Bruin A; Cuppen E; Simonis M
PLoS One; 2015; 10(3):e0122066. PubMed ID: 25811670
[TBL] [Abstract][Full Text] [Related]
9. DNA damage response, checkpoint activation and dysfunctional telomeres: face to face between mammalian cells and Drosophila.
Cipressa F; Cenci G
Tsitologiia; 2013; 55(4):211-7. PubMed ID: 23875450
[TBL] [Abstract][Full Text] [Related]
10. Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders.
Panero J; Stella F; Schutz N; Fantl DB; Slavutsky I
PLoS One; 2015; 10(9):e0137972. PubMed ID: 26366868
[TBL] [Abstract][Full Text] [Related]
11. Integrated evaluation of telomerase activation and telomere maintenance across cancer cell lines.
Hu K; Ghandi M; Huang FW
Elife; 2021 Sep; 10():. PubMed ID: 34486523
[TBL] [Abstract][Full Text] [Related]
12. Retrotransposon-derived p53 binding sites enhance telomere maintenance and genome protection.
Lieberman PM
Bioessays; 2016 Oct; 38(10):943-9. PubMed ID: 27539745
[TBL] [Abstract][Full Text] [Related]
13. Telomere dynamics in mammals.
Silvestre DC; Londoño-Vallejo A
Genome Dyn; 2012; 7():29-45. PubMed ID: 22759812
[TBL] [Abstract][Full Text] [Related]
14. Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening.
Carrillo J; Calvete O; Pintado-Berninches L; Manguan-García C; Sevilla Navarro J; Arias-Salgado EG; Sastre L; Guenechea G; López Granados E; de Villartay JP; Revy P; Benitez J; Perona R
Hum Mol Genet; 2017 May; 26(10):1900-1914. PubMed ID: 28369633
[TBL] [Abstract][Full Text] [Related]
15. Germline mutation of
Toufektchan E; Lejour V; Durand R; Giri N; Draskovic I; Bardot B; Laplante P; Jaber S; Alter BP; Londono-Vallejo JA; Savage SA; Toledo F
Sci Adv; 2020 Apr; 6(15):eaay3511. PubMed ID: 32300648
[TBL] [Abstract][Full Text] [Related]
16. Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome.
Steinbrecher D; Jebaraj BMC; Schneider C; Edelmann J; Cymbalista F; Leblond V; Delmer A; Ibach S; Tausch E; Scheffold A; Bloehdorn J; Hallek M; Dreger P; Döhner H; Stilgenbauer S
Leuk Lymphoma; 2018 Jul; 59(7):1614-1623. PubMed ID: 29063805
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53.
Ju YJ; Park JE; Juhn KM; Jeong J; Yun M; Park MJ; Park GH; Choi KY; Cho MH; Wong KK; Park WB; Lee KH
Int J Oncol; 2006 Oct; 29(4):753-63. PubMed ID: 16964373
[TBL] [Abstract][Full Text] [Related]
18. Super-telomeres in transformed human fibroblasts.
Chiodi I; Belgiovine C; Zongaro S; Ricotti R; Horard B; Lossani A; Focher F; Gilson E; Giulotto E; Mondello C
Biochim Biophys Acta; 2013 Aug; 1833(8):1885-93. PubMed ID: 23570868
[TBL] [Abstract][Full Text] [Related]
19. Genomic instability in both wild-type and telomerase null MEFs.
Hao LY; Greider CW
Chromosoma; 2004 Sep; 113(2):62-8. PubMed ID: 15258806
[TBL] [Abstract][Full Text] [Related]
20. Oxidative DNA damage in Barrett mucosa: correlation with telomeric dysfunction and p53 mutation.
Cardin R; Piciocchi M; Tieppo C; Maddalo G; Zaninotto G; Mescoli C; Rugge M; Farinati F
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S583-9. PubMed ID: 23744553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]